Antimicrobial

Aridis Meets Primary and Secondary Endpoints in Phase 2a Study of AR-501 in Cystic Fibrosis Patients

The study achieved high uptake of AR-501 in the respiratory tract at levels that were more than 50-fold higher than…

1 year ago

Chiara Family Foundation Winter Classic hockey game raises $300,000 in support of the MUHC Foundation

Chiara Family Foundation Winter Classic hockey game raises $300,000 in support of the MUHC Foundation The game between Montreal Canadiens…

1 year ago

BioLife Sciences, Inc. (OTC:PK BLFE) (BioLife or the Company) is Pleased to Announce the Release of the Prototype of the Company’s Copper-Infused Microfiber Towels for Q2 of the Fiscal Year

HENDERSON, NV, Feb. 23, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – The Copper-Infused Microfiber Towels are copper-variations of traditional microfiber…

1 year ago

Endomimetics™ Announces a Research Collaboration Agreement with BISCO, Inc., to Support Development of a Dental Application of Bionanomatrix™

Funding matches Alabama Research and Development Enhancement Fund (ARDEF) grant to Kyounga Cheon, D.M.D., M.S., Associate Professor at the School…

1 year ago

BioLife Sciences Inc. (OTC: BLFE) Announces Letter of Intent for Exclusive Licensing Deal with Canadian Firm

HENDERSON, NV, Feb. 02, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences (OTCPK: BLFE) is pleased to announce that it has entered into…

1 year ago

OpGen subsidiary Ares Genetics announces granting of key patent in China

Patent covers the identification and diagnostic use of genomic variants for the diagnosis of antibiotic resistant bacteriaThe China National Intellectual…

1 year ago

Paratek Pharmaceuticals Announces Inclusion of NUZYRA® (omadacycline) in China’s National Reimbursement Drug List (NRDL)

National Healthcare Security Administration Adds NUZYRA to NRDL for Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin…

1 year ago

US Department of Defense Uniformed Services University Clinical Evaluation of Travelan™ Achieves 150 Recruitment Milestone

Highlights: First participants enrolled in USU Travelan Clinical Trial Field Study157 participants successfully randomized into the Clinical StudyPlans in place…

1 year ago

Qualigen Therapeutics Provides Update on Developments at NanoSynex; Significant Progress Reported on Infectious Disease Diagnostic Platform

CARLSBAD, Calif., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified life…

2 years ago